SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Arbutus Biopharma
An SI Board Since February 2014
Posts SubjectMarks Bans Symbol
42 7 0 ABUS
Emcee:  donpat Type:  Moderated
Introduction Market Data Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
17This should be the last Ebola outbreak without a treatment, Winnipeg expert saysdonpat-7/23/2014
16Yes, IMO, to the question.....The Ox-7/22/2014
15Tekmira Pharmaceuticals: Is The Clinical Hold Sell-Off A Buying Opportunity? Jdonpat-7/22/2014
14Tekmira Receives $1.5 Million Milestone Payment VANCOUVER, British Columbia, Judonpat-7/9/2014
13Tekmira Pharmaceuticals Corp Coverage Initiated by Analysts at RBC Capital (TKMRdonpat-4/15/2014
12Tekmira Awarded $140 Million Contract For Ebola Treatment Research April 10, 20donpat-4/11/2014
11Tekmira’s three leading relationships in the RNAi therapeutics field are Alnylamdonpat-3/7/2014
10Alnylam Pharmaceuticals acquires Sirna Therapeutics from Merck Mar 07, 2014 (Medonpat-3/7/2014
9I wonder if HIV could/will be remedied by this Tekmira siRNA approach?? I mean donpat-3/6/2014
8"suggest that this strategy might also be useful for treatment of other emedonpat-3/6/2014
7My story: Got interested in NanoViricides(NNVC) from day one because I love nandonpat-3/6/2014
6Wow....this is nice!! Thank you. What is your story to finding this stock?? Time2shine-3/6/2014
5Tekmira Pharmaceuticals Corp After Hours Trading TKMR $27.19 * 2.27 [gradonpat-3/5/2014
4 16:11 EDT [graphic] TKMR Tekmira receives fast track designationfrom FDA for Tdonpat-3/5/2014
3More Than a Messenger: A New Class of Drugs—mRNA-Based Therapeutics BioPerspedonpat-3/5/2014
2Tekmira Presents Recent Advances in mRNA Delivery at Scientific Symposium VANCOdonpat-2/28/2014
1Synthetic mRNA can induce self-repair and regeneration of the infarcted heart donpat-2/28/2014
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News